Wednesday, July 8, 2026

pharma · Advanced Solid Tumor · Acute Myeloid Leukemia or Myelodysplastic Syndromes · APRE

Aprea Therapeutics

News and analysis for Aprea Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

3805 Old Easton Rd, Doylestown, Pennsylvania 18902, US HQ
15 Employees
Public company Type
APRE · NYSE Ticker
Company details
Status
Public
HQ
3805 Old Easton Rd, Doylestown, Pennsylvania 18902, US
Employees
15
Programs
15
Drugs
5
Patents
6
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Aprea Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Aprea Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Aprea Therapeutics yet.

Back to company overview →